MNV
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

SGMO Crosses Below Key Moving Average Level
Wednesday, April 25, 11:43 AM ET, by Market News Video Staff

In trading on Wednesday, shares of Sangamo Therapeutics Inc (SGMO) crossed below their 200 day ...

Notable Two Hundred Day Moving Average Cross - GHDX
Monday, April 30, 11:54 AM ET, by Market News Video Staff

In trading on Monday, shares of Genomic Health Inc (GHDX) crossed below their 200 day ...

Investors Snag SGMO Even Lower Than Its Secondary Stock Offering
Monday, April 30, 1:39 PM ET, by Market News Video Staff

Looking back to 5 days ago, Sangamo Therapeutics Inc (SGMO) priced a 12,310,000 share secondary ...

CytomX Therapeutics Enters Oversold Territory
Thursday, May 3, 4:36 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Repligen (RGEN) Shares Cross Above 200 DMA
Monday, May 7, 11:26 AM ET, by Market News Video Staff

In trading on Monday, shares of Repligen Corp. (RGEN) crossed above their 200 day moving ...

MYGN Crosses Below Key Moving Average Level

By Market News Video Staff, Tuesday, March 13, 11:45 AM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Myriad Genetics, Inc. (NASDAQ:MYGN) crossed below their 200 day moving average of $31.03, changing hands as low as $28.51 per share. Myriad Genetics, Inc. shares are currently trading off about 9.5% on the day. The chart below shows the one year performance of MYGN shares, versus its 200 day moving average:

Myriad Genetics, Inc. 200 Day Moving Average Chart

Looking at the chart above, MYGN's low point in its 52 week range is $17.50 per share, with $41.57 as the 52 week high point that compares with a last trade of $29.79.


Special Offer: Receive our best dividend ideas directly to your inbox each afternoon with the Dividend Channel Premium Newsletter

According to the ETF Finder at ETF Channel, MYGN makes up 2.73% of the PowerShares Dynamic Biotechnology & Genome Portfolio ETF (NYSE:PBE) which is trading lower by about 0.8% on the day Tuesday.

See what other ETFs contain MYGN
See what other stocks are held by PBE


This Article's Word Cloud:   According   Average   Below   Biotechnology   Channel   Crossing   Dividend   Dynamic   ETFs   Finder   Genetics   Genome   Looking   MYGN   Moving   Myriad   NYSE   Newsletter   Offer   Portfolio   PowerShares   Premium   Receive   Special   Start   Stocks   Their   Tuesday   about   above   afternoon   average   below   best   changing   chart   compares   contain   crossed   currently   directly   moving   other   point   share   shares   trading   week   what   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

MYGN Crosses Below Key Moving Average Level | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.